Your browser doesn't support javascript.
loading
Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis.
Avallone, G; Cariti, C; Dapavo, P; Ortoncelli, M; Conforto, L; Mastorino, L; Roccuzzo, G; Cavallo, F; Rubatto, M; Quaglino, P; Ribero, S.
Affiliation
  • Avallone G; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Cariti C; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Dapavo P; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Ortoncelli M; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Conforto L; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Mastorino L; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Roccuzzo G; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Cavallo F; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Rubatto M; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Quaglino P; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Ribero S; Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
J Eur Acad Dermatol Venereol ; 36(7): e574-e576, 2022 07.
Article in En | MEDLINE | ID: mdl-35279885

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis Limits: Humans Language: En Journal: J Eur Acad Dermatol Venereol Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis Limits: Humans Language: En Journal: J Eur Acad Dermatol Venereol Year: 2022 Document type: Article